社会经济地位与类风湿关节炎患者的药物使用:范围综述
该范围综述检索了Medline、Embase和PsychInfo自建库至2022年2月的文献,纳入81项评估社会经济地位(SES)与药物使用结局的研究。多数研究记录了至少1项SES指标与药物使用差异相关,但SES定义多样使研究间比较困难;作者认为需以前瞻性研究及统一定义的SES来确定药物使用差异是否解释低SES患者较差结局。
要点
- 多数纳入研究记录了至少1项SES指标与药物使用差异相关。
- SES测量以教育、地区层面SES和收入最常用,研究中位测量4项SES变量。
- SES定义多样使研究间比较困难,作者认为需前瞻性研究及统一定义SES。
核心结论
- 有一些证据表明SES影响RA患者的药物使用,但SES定义多样使研究间比较困难。
- 作者认为需以前瞻性研究及统一定义的SES来确定药物使用差异是否解释低SES患者较差的结局。
研究设计与样本
- 范围综述,检索Medline、Embase和PsychInfo自建库至2022年2月,纳入评估SES与药物使用作为结局变量的研究。
- 共识别2103项研究,其中81项被选入分析。
- 纳入研究最常来自美国(42%),参与者平均±标准差年龄为55.9±6.8岁,大多数为女性(75%)。
主要发现
- 研究测量的SES变量中位数为4项(四分位距3-6),教育、地区层面SES和收入是最常用的测量。
- 34项研究记录了患者的种族和/或族裔。
- 研究主要评估改善病情抗风湿药处方或调配的可能性、用药依从性或治疗延迟。
- 多数研究记录了至少1项SES指标与药物使用差异相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- SES定义多样,使研究间比较困难。
- 作者认为需以前瞻性研究及统一定义的SES来确定药物使用差异是否解释低SES患者较差的结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Socioeconomic status (SES) influences disease outcomes in rheumatoid arthritis (RA) patients. Differences in medication use may partly explain this association. A scoping review was used to identify research conducted on this topic and determine what knowledge gaps remain. METHODS: Medline, Embase, and PsychInfo were searched from their inception until February 2022 for studies that assessed SES and medication use as an outcome variable. Data was extracted on the use of specific SES measures, medication use, and whether differences in SES variables were associated with differences in medication use. RESULTS: We identified 2,103 studies, of which 81 were selected for inclusion. Included studies originated most frequently from the US (42%); the mean ± SD age of participants was 55.9 ± 6.8 years, and most were female (75%). Studies measured a median of 4 SES variables (interquartile range 3-6), with educational, area-level SES, and income being the most frequent measurements used. Patients' race and/or ethnicity were documented by 34 studies. Studies primarily assessed the likelihood of prescription of disease-modifying antirheumatic drugs or dispensation, medication adherence, or treatment delays. A majority of studies documented at least 1 SES measure associated with a difference in medication use. CONCLUSION: There is some evidence that SES affects use of medications in patients with RA; however, multiple definitions of SES have been utilized, making comparisons between studies difficult. Prospective studies with consistently defined SES will be needed to determine whether differences in medication use accounts for the poorer outcomes experienced by patients of lower SES.
引用
- Russell O, Lester S, Black RJ, et al. Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review. Arthritis Care Res (Hoboken). 2022. PMID: 36106932. doi:10.1002/acr.25024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。